Polycystic ovary syndrome has been renamed polyendocrine metabolic ovarian syndrome. The change reflects the biological ...

A shift from PCOS to PMOS, or Polyendocrine Metabolic Ovarian Syndrome, reflects a deeper understanding of this complex ...

Polycystic Ovary Syndrome, which has just been renamed Polyendocrine Ovarian Syndrome (PMOS), is the most common hormonal and metabolic disorder affecting women of reproductive age, impacting up to 13 ...

Polycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMOS), a move health experts say will lead to faster diagnoses and better treatment for women of all ages.

Nonalcoholic fatty liver disease (NAFLD) is a prevalent metabolic disorder with a complex pathogenesis. Although epitranscriptomic modifications such as N6-methyladenosine (m6A) have been implicated ...

PMOS is not primarily a disease of the ovaries. Its new name reflects the condition’s more complex and cyclical endocrine and ...

People with comorbid alcohol use disorder and obesity may represent a distinct clinical subgroup, with glucose dysregulation ...

Doctors are discussing replacing the term PCOS with names like PMOs or Poly Endocrine Metabolic Syndrome to better reflect the condition's hormonal and metabolic impact. Experts say the change could ...

Long criticized for its inaccuracy, the name of polycystic ovary syndrome is changing. A global consensus of experts has just adopted a new name, considered more faithful to the reality of the disease ...

Many studies have examined how rheumatoid arthritis therapy affects the risk of metabolic comorbidities. Though metabolic disruption can have significant long-term adverse outcomes for people with ...